Brian C Stephenson, Chief Financial Officer at Faeth Therapeutics, bought SNSE on Jul 1, 2026
Prices as of Jun 11 · price update delayed · Every feed →
▲ BUY$103K4,400 shares at $23.40Brian C Stephenson Chief Financial OfficerSNSE Faeth Therapeutics, Inc.
- Traded
- Jul 1, 2026
- Disclosed
- Jul 1, 2026
- Filed
- The same day
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
SNSE since disclosure
SNSE has not closed a trading day since the disclosure yet
Similar stocks (XLV) since disclosure
SNSE has not closed a trading day since the disclosure yet
XLV — its sector index fund
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▲ BUYBrian C Stephenson Chief Financial OfficerSNSE Faeth Therapeutics, Inc.$14.5Kdisclosed Jul 1 · filed the same day
- ▲ BUYBrian C Stephenson Chief Financial OfficerSNSE Faeth Therapeutics, Inc.$43.8Kdisclosed Jul 1 · filed 1 day after the trade
- ▲ BUYBrian C Stephenson Chief Financial OfficerSNSE Faeth Therapeutics, Inc.$106Kdisclosed Jul 1 · filed 1 day after the trade
- ▲ BUYBrian C Stephenson Chief Financial OfficerSNSE Faeth Therapeutics, Inc.$39.1Kdisclosed Jul 1 · filed 1 day after the trade
- ▲ BUYBrian C Stephenson Chief Financial OfficerSNSE Faeth Therapeutics, Inc.$19.4Kdisclosed Jul 1 · filed 2 days after the trade